drugset / Trial / NCT00367120

Zmax Compared to Augmentin in Sinusitis

NCT00367120

Phase 4 Completed 762 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will enroll patients with Bacterial Sinusitis who will be treated with either Zmax (Azithromycin Extended Release) or Augmentin (Amoxicillin/Clavulanate). The purpose of the study is to compare early resolution of symptoms between the two treatments. Patients will report resolution of their sinusitis symptoms through a daily questionnaire. There will be two follow-up telephone interviews on days 12 and 28 to evaluate quality of life, satisfaction with therapy, and use of healthcare services.

Timeline

Start
2006-06
Primary completion
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin/Clavulanate Unknown
Subject Azithromycin Small molecule

Indications